Delivery Order SPE2DB22D3004-SPE2DB25FRM93
Award Date 7/18/25
Potential Completion Date 8/8/25
Potential Value $8.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,490.17 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 21 capsules of IBRANCE 75 MG to support Conshohocken, Pennsylvania operations. IBRANCE is a pharmaceutical used to treat breast cancer. The order was placed under an unspecified multiple award contract vehicle and has a period of performance from September 8, 2023 through September 29, 2023. No subcontractors or set aside designations were identified. The...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,797.84 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to...
- This is a $8,123.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of IBRANCE 75 MG TABLET 7S, a prescription pharmaceutical product, with a performance period ending on June 26, 2025. This award is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,122.48 firm fixed-price delivery order covers the supply of IBRANCE 100 MG TABLET 7S, a medication, with a performance period through June 6, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,118.08 contract is for the delivery of the medication Ibrance 125 mg Tablet 7s, with a performance period ending on May 19, 2025. This delivery order is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides global pharmaceutical support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 75 MG TABLET 7S, a prescription medication. The contract has a firm fixed price and a ceiling value of $24,371.88. It is not a set-aside contract, indicating open competition. The contract is a delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,792.08 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract...
- The U.S. government awarded a Delivery Order contract worth $15,592.60 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide IBRANCE 100 MG TABLET 7S. This Delivery Order was issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at $999,999,999 and running through November 2026. The IDC enables the government to efficiently procure a comprehensive range of pharmaceutical products and medical supplies,...
- This is a $8,122.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG TABLET 7S, a prescription medication, with a period of performance ending on July 8, 2025. The contract is not set aside and is awarded as part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This is a $8,122.48 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG TABLET 7S, with a period of performance ending on June 9, 2025. The award was made on May 16, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...